Efficacy and Safety of Inhaled Compared With Subcutaneous Human Insulin Therapy in Subjects With Type 1 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial
Efficacy and Safety of Inhaled Compared With Subcutaneous Human Insulin Therapy in Subjects With Type 1 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial
To determine, in subjects with Type 1 Diabetes Mellitus:
Inclusion Criteria:
Exclusion Criteria:
Any smoking within the last 6 months. Smoking is not permitted at any time during this study.